HLA-DR/HLA-DRA/HLA Mouse Monoclonal Antibody, Clone: [8I10H1], Unconjugated

Catalog Number: BYT-ORB1152389
Article Name: HLA-DR/HLA-DRA/HLA Mouse Monoclonal Antibody, Clone: [8I10H1], Unconjugated
Biozol Catalog Number: BYT-ORB1152389
Supplier Catalog Number: orb1152389
Alternative Catalog Number: BYT-ORB1152389-100
Manufacturer: Biorbyt
Host: Mouse
Category: Antikörper
Application: FC, IHC, WB
Species Reactivity: Human
Immunogen: E.coli-derived human HLA-DR/HLA-DRA recombinant protein (Position: I26-L254).
Conjugation: Unconjugated
Alternative Names: HLA DRA, HLA DRA1, HLA-DR, HLA-DRA, MHC class II antigen DRA
Anti-HLA-DR/HLA-DRA Antibody (monoclonal, 8I10H1). Tested in Flow Cytometry, IHC, WB applications. This antibody reacts with Human.
Clonality: Monoclonal
Concentration: Adding 0.2 ml of distilled water will yield a concentration of 500 µg/ml.
Clone Designation: [8I10H1]
Molecular Weight: 35-37 kDa
UniProt: P01903
Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl and 0.2 mg Na2HPO4.
Form: Lyophilized
Target: HLA class II histocompatibility antigen, DR alpha chain
Application Dilute: Western blot, 0.25-0.5 µg/ml, Human Immunohistochemistry(Paraffin-embedded Section), 2-5 µg/ml, Human Flow Cytometry (Fixed), 1-3 µg/1x10 6 cells, Human
Flow Cytometry analysis of Daudi cells using anti-HLA-DRA antibody. Overlay histogram showing Daudi cells (Blue line). The cells were fixed with 4% paraformaldehyde and blocked with 10% normal goat serum. And then incubated with mouse anti-HLA-DRA Antibody (1 µg/1x10 6 cells) for 30 min at 20C. DyLight488 conjugated goat anti-mouse IgG (5-10 µg/1x10 6 cells) was used as secondary antibody for 30 minutes at 20C. Isotype control antibody (Green line) was mouse IgG (1 µg/1x10 6) used under the same conditions. Unlabelled sample without incubation with primary antibody and secondary antibody (Red line) was used as a blank control.
IHC analysis of HLA-DRA using anti-HLA-DRA antibody. HLA-DRA was detected in a paraffin-embedded section of human laryngeal squamous cell carcinoma tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 µg/ml mouse anti-HLA-DRA Antibody overnight at 4C. Peroxidase Conjugated Goat Anti-mouse IgG was used as secondary antibody and incubated for 30 minutes at 37C. The tissue section was developed using HRP Conjugated Mouse IgG Super Vision Assay Kit with DAB as the chromogen.
IHC analysis of HLA-DRA using anti-HLA-DRA antibody. HLA-DRA was detected in a paraffin-embedded section of human mammary infiltrate tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 µg/ml mouse anti-HLA-DRA Antibody overnight at 4C. Peroxidase Conjugated Goat Anti-mouse IgG was used as secondary antibody and incubated for 30 minutes at 37C. The tissue section was developed using HRP Conjugated Mouse IgG Super Vision Assay Kit with DAB as the chromogen.
IHC analysis of HLA-DRA using anti-HLA-DRA antibody. HLA-DRA was detected in a paraffin-embedded section of human rectal cancer tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 µg/ml mouse anti-HLA-DRA Antibody overnight at 4C. Peroxidase Conjugated Goat Anti-mouse IgG was used as secondary antibody and incubated for 30 minutes at 37C. The tissue section was developed using HRP Conjugated Mouse IgG Super Vision Assay Kit with DAB as the chromogen.
IHC analysis of HLA-DRA using anti-HLA-DRA antibody. HLA-DRA was detected in a paraffin-embedded section of human tonsil tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 µg/ml mouse anti-HLA-DRA Antibody overnight at 4C. Peroxidase Conjugated Goat Anti-mouse IgG was used as secondary antibody and incubated for 30 minutes at 37C. The tissue section was developed using HRP Conjugated Mouse IgG Super Vision Assay Kit with DAB as the chromogen.
Western blot analysis of HLA-DRA using anti-HLA-DRA antibody. Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human Raji whole cell lysates, Lane 2: human Daudi whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with mouse anti-HLA-DRA antigen affinity purified monoclonal antibody at 0.5 µg/mL overnight at 4C, then washed with TBS-0.1% Tween 3 times with 5 minutes each and probed with a goat anti-mouse IgG-HRP secondary antibody at a dilution of 1:10000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit with Tanon 5200 system.
IHC analysis of HLA-DRA using anti-HLA-DRA antibody. HLA-DRA was detected in a paraffin-embedded s